Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lung

Internal Medicine

Volumn 43, Issue 7, 2004, Pages 602-606

  Konishi, Jun ^c   Yamazaki, Koichi ^c   Chikai, Kanako ^a   Nagashima, Kazuo ^a   Sakai, Koichiro ^b   Kinoshita, Ichiro ^a   Dosaka Akita, Hirotoshi ^a   Nishimura, Masaharu ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kanazawa Medical University   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Paraneoplastic cerebellar degeneration; Purkinje cells; Squamous cell carcinoma of the lung

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; ASTROCYTOSIS; AUTOPSY; CANCER STAGING; CASE REPORT; CEREBELLUM DEGENERATION; CEREBELLUM DISEASE; CEREBROSPINAL FLUID EXAMINATION; HUMAN; LUNG SQUAMOUS CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLEOCYTOSIS; PURKINJE CELL;

AGED; AUTOPSY; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PARANEOPLASTIC CEREBELLAR DEGENERATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4444241952     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.602     Document Type: Article

References (23)

1. Darnell RB, DeAngelis LM. Repression of small cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341: 21-22, 1993.
2. Horwich MS, Cho L, Porro RS, Posner JB. Subacute sensory neuropathy: A remote effect of carcinoma. Ann Neurol 2: 7-19, 1977.
3. Anderson NE, Rosenbulm MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 24: 559-567, 1988.
4. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14: 609-613, 1983.
5. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322: 1844-1851, 1990.
6. Lennon VA. The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies. Neurology 44: 2412-2415, 1994.
7. Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 74: 55-61, 1997.
8. Clouston PD, Saper CB, Arbizu T, et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42: 1944-1950, 1992.
9. Moll JWB, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from Workshop to the Fourth Meeting of the International Society of Neuroimmunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, the Netherlands. Neurology 45: 1937-1941, 1995.
10. Dropcho EJ. Paraneoplastic disorders: antineuronal antibodies and therapeutic options. Semin Neurol 14: 179-187, 1994.
11. Peterson K, Rosenbulm MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo-positive patients. Neurology 42: 1931-1937, 1992.
12. Dalmau J, Graus F, Roselbum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy. A clinical study of 71 patients. Medicine 71: 59-72, 1992.
13. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol 27: 544-552, 1990.
14. Bernal F, Shams'ili S, Rojas I, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60: 230-234, 2003.
15. Lovblad KO, Boucraut J, Lehmann HP, Stahel R, Regli F, Steck AJ. Autoantibodies in neurological paraneoplastic diseases. Schweiz Arch Neurol Psychiatr 145: 3-7, 1994.
16. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 9: 275-284, 1999.
17. Satton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci 102: 475-486, 2002.
18. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4: 1321-1324, 1998.
19. Furihata M, Sonobe H, Iwata J, et al. Lung squamous cell carcinoma producing both parathyroid hormone-related peptide and granulocyte colony stimulating factor. Pathol Int 46: 376-379, 1996.
20. Graus F, Vega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42: 536-540, 1992.
21. Furneaux HF, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085-1091, 1990.
22. Rojas I, Graus F, Keime-Guibert F, et al. Long-term clinical out come of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55: 713-715, 2000.
23. Keime-Guibert F, Graus F, Broet P, et al. Clinical outcome of patients with anti-Hu associated encephalomyelitis after treatment of the tumor. Neurology 53: 1719-1723, 1999.